You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 131 No. 4, April 1996 TABLE OF CONTENTS
  Archives
  •  Online Features
  ORIGINAL ARTICLES
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Multimodal-Therapy Breast Salvage in the Urban Poor With Locally Advanced Cancer

Arthur W. Boddie, Jr, MD; M. Warso, MD; H. Briele, MD; P. Sweeney, MD; N. Low, MD; J. Bork, MD; Noi Rattan, RN, PhD; Linda Wild, RN

Arch Surg. 1996;131(4):424-428.


Abstract

Objectives
To determine whether economically disadvantaged urban women with locally advanced breast cancer (American Joint Committee on Cancer stages IIB to IIIB) have rates of response to sequential neoadjuvant chemotherapy and radiation, breast salvage rates, overall survival rates, and disease-free survival rates comparable with those previously reported in other socioeconomic groups and to compare these variables in different ethnic groups within the study population.

Design
Prospective, nonrandomized, case series.

Setting
Urban county hospital.

Patients
Thirty-seven women with locally advanced breast cancer who came to the breast clinic at Cook County Hospital, Chicago, Ill, during a 3-year interval.

Intervention
Sequential chemoradiation followed by surgery in selected patients.

Main Outcome Measures
Comparison of clinical response rates, disease-free survival rates, and breast salvage rates between different ethnic groups in the study population.

Results
In the entire group, the overall response rate to neoadjuvant chemotherapy was 73%, with a complete response rate of 32%. Twenty-five percent of patients whose tumors responded incompletely to chemotherapy had a complete response after subsequent radiation. With a mean follow-up of 18.7 months, 65% of patients had no evidence of disease, and breast salvage without evidence of recurrent disease was achieved in 38% of patients. No differences in overall response rates, breast salvage rates, or early disease-free survival rates were observed within different ethnic groups in the study population, and these results are generally comparable with previously reported results in other socioeconomic groups.

Conclusion
These results do not show significant differences in responses to sequential chemotherapy and irradiation, in breast salvage rates, or in survival between different ethnic groups in this study population.

(Arch Surg. 1996;131:424-428)



Author Affiliations

From the Division of Surgical Oncology, Cook County Hospital, Chicago, Ill (Drs Boddie, Warso, Briele, and Bork and Ms Rattan) and the Departments of Surgical Oncology (Drs Boddie, Warso, and Briele and Ms Wild) and Radiation Therapy (Drs Sweeney and Low), University of Illinois at Chicago.



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Invited Commentary
Matory
Arch Surg 1996;131:429-429.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1996 American Medical Association. All Rights Reserved.